1. Home
  2. RVPH vs VGI Comparison

RVPH vs VGI Comparison

Compare RVPH & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVPH
  • VGI
  • Stock Information
  • Founded
  • RVPH 2006
  • VGI 2012
  • Country
  • RVPH United States
  • VGI United States
  • Employees
  • RVPH N/A
  • VGI N/A
  • Industry
  • RVPH Biotechnology: Pharmaceutical Preparations
  • VGI Investment Managers
  • Sector
  • RVPH Health Care
  • VGI Finance
  • Exchange
  • RVPH Nasdaq
  • VGI Nasdaq
  • Market Cap
  • RVPH 88.0M
  • VGI 91.4M
  • IPO Year
  • RVPH N/A
  • VGI N/A
  • Fundamental
  • Price
  • RVPH $1.98
  • VGI $7.91
  • Analyst Decision
  • RVPH Strong Buy
  • VGI
  • Analyst Count
  • RVPH 5
  • VGI 0
  • Target Price
  • RVPH $11.40
  • VGI N/A
  • AVG Volume (30 Days)
  • RVPH 2.2M
  • VGI 46.0K
  • Earning Date
  • RVPH 11-14-2024
  • VGI 01-01-0001
  • Dividend Yield
  • RVPH N/A
  • VGI 12.66%
  • EPS Growth
  • RVPH N/A
  • VGI N/A
  • EPS
  • RVPH N/A
  • VGI N/A
  • Revenue
  • RVPH N/A
  • VGI N/A
  • Revenue This Year
  • RVPH N/A
  • VGI N/A
  • Revenue Next Year
  • RVPH N/A
  • VGI N/A
  • P/E Ratio
  • RVPH N/A
  • VGI N/A
  • Revenue Growth
  • RVPH N/A
  • VGI N/A
  • 52 Week Low
  • RVPH $0.60
  • VGI $6.68
  • 52 Week High
  • RVPH $4.83
  • VGI $7.99
  • Technical
  • Relative Strength Index (RSI)
  • RVPH 56.56
  • VGI 66.05
  • Support Level
  • RVPH $1.78
  • VGI $7.70
  • Resistance Level
  • RVPH $1.91
  • VGI $7.74
  • Average True Range (ATR)
  • RVPH 0.18
  • VGI 0.09
  • MACD
  • RVPH -0.00
  • VGI 0.03
  • Stochastic Oscillator
  • RVPH 86.00
  • VGI 90.91

About RVPH Reviva Pharmaceuticals Holdings Inc.

Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, and Parkinson's disease psychosis and its other drug candidate is RP1208.

About VGI Virtus Global Multi-Sector Income Fund of Beneficial Interest

Virtus Global Multi-Sector Inc is a United States-based diversified, closed-end management investment company. Its investment objective is to maximize current income while preserving capital. The Fund seeks to achieve its investment objectives by capitalizing on opportunities across undervalued areas of the global bond markets.

Share on Social Networks: